| Literature DB >> 34568147 |
Abeer S Alshuniefi1, Nasser K Aljuhani2, Abrar H Allafi1, Mashael S Alruwayshid1, Enas F Alaraik3, Fatmah Alreshidi4, Ebtehaj S Almughais4.
Abstract
CONTEXT: Metabolic syndrome (MS) is a group of metabolism diseases which includes over increase of the body weight, high insulin levels, elevated blood pressure, and abnormal level of cholesterol; these disorders may increase the risk of evolving coronary heart diseases. Primary health care physicians are responsible for caring for general patients and thus must have sufficient knowledge about MS, positive attitudes, and good medical practices. AIMS: To evaluate the knowledge, attitudes, and practices of family medicine residents in Riyadh regarding the diagnosis, management, and preventive measures of MS. METHODS AND MATERIAL: This study is a cross-sectional; it was conducted on family medicine residents in Riyadh using a survey to investigate the demographics, knowledge, attitudes, and practices of the residents regarding MS.Entities:
Keywords: Attitude; Riyadh; family medicine residents; knowledge; metabolic syndrome; practice
Year: 2021 PMID: 34568147 PMCID: PMC8415643 DOI: 10.4103/jfmpc.jfmpc_1744_20
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Characteristics of the family medicine residents
| Variables | Description ( |
|---|---|
| Age (years) | |
| Range | 24-40 |
| Mean±SD | 27.6±2.3 |
| Age Group | |
| <30 | 195 (87.1) |
| ≥30 | 29 (12.9) |
| Sex | |
| Male | 106 (47.3) |
| Female | 118 (52.7) |
| Nationality | |
| Saudi | 222 (99.1) |
| Non-Saudi | 2 (0.9) |
| Training Centre | |
| KFMC | 95 (42.4) |
| KSMC | 53 (23.7) |
| KSUMC | 25 (11.2) |
| SFH | 14 (6.3) |
| PSMMC | 25 (11.2) |
| NGHA | 3 (1.3) |
| PMAH | 9 (4) |
| Training Level | |
| R1 | 67 (29.9) |
| R2 | 55 (24.6) |
| R3 | 62 (27.7) |
| R4 | 40 (17.9) |
KFMC: King Fahad Medical city, KSMC: King Saud Medical City, KSUMC: King Saud University medical City, SFH: Security Force Hospital, PSMMC: Prince Sultan Military Medical City, NGHA: National Guard Health Affairs, PMAH: Prince Mohammed bin abdulaziz Hospital
Questions and responses of family medicine residents regarding MS knowledge
| Knowledge questions | Yes (%) | No (%) | I do not know (%) |
|---|---|---|---|
| Metabolic syndrome (MS) is related to central obesity, dyslipidemia, increased blood pressure, and impaired glucose tolerance | 217 (96.9) | 4 (1.8) | 3 (1.3) |
| Overall-The overall age-adjusted prevalence of MS in the KSA according to the study of Al-Nozha | 44 (19.6) | 7 (3.1) | 173 (77.2) |
| FBS >100 mg/dl, which includes diabetic patients, is consistent with the diagnosis of MS according to the International Diabetic Foundation | 74 (33) | 75 (33.5) | 75 (33.5) |
| Increased waist circumference is a necessary criterion for MS diagnosis | 155 (69.2) | 37 (16.5) | 32 (14.3) |
| The primary aim for MS management with lipid-lowering agents is to decrease LDL, increase HDL, and decrease TG | 162 (72.3) | 28 (12.5) | 34 (15.2) |
| In patients with established diabetes, the goal of antihypertensive therapy is to maintain blood pressure below 130/80 mmHg | 170 (75.9) | 38 (17) | 16 (7.1) |
Questions and responses of family medicine residents regarding attitude toward MS
| Attitude | Strongly agree (%) | Agree (%) | Neutral (%) | Disagree (%) | Strongly disagree (%) |
|---|---|---|---|---|---|
| Metabolic syndrome (MS) is common worldwide, particularly in the KSA | 102 (45.5) | 92 (41.1) | 28 (12.5) | 2 (0.9) | 0 (0) |
| MS diagnosis is difficult to diagnose MS at PHCCs in Riyadh | 15 (6.7) | 28 (12.5) | 61 (27.2) | 83 (37.1) | 37 (16.5) |
| MS patients must be seen on a regular basis to screen for diabetes, hypertension, and dyslipidemia even if these conditions have not developed yet | 80 (35.7) | 98 (43.8) | 39 (17.4) | 7 (3.1) | 0 (0) |
| Management of MS generally is effective | 85 (37.9) | 105 (46.9) | 31 (13.8) | 3 (1.3) | 0 (0) |
| Patients with MS should be managed by specialists | 16 (7.1) | 46 (20.5) | 86 (38.4) | 56 (25) | 20 (8.9) |
| I am confident diagnosing patients with MS | 47 (21) | 87 (38.8) | 75 (33.5) | 14 (6.3) | 1 (0.4) |
| I am confident managing patients with MS | 41 (18.3) | 99 (44.2) | 62 (27.7) | 20 (8.9) | 2 (0.9) |
| I feel that I should know more about MS | 88 (39.3) | 98 (43.8) | 35 (15.6) | 3 (1.3) | 0 (0) |
| I need to attend trainings about MS | 65 (29) | 83 (37.1) | 67 (29.9) | 6 (2.7) | 3 (1.3) |
Questions and responses of family medicine residents regarding MS practices
| Questions and responses | Description ( |
|---|---|
| Do you screen for MS after a diagnosis of essential HTN? | |
| Always | 53 (23.7) |
| Sometimes | 115 (51.3) |
| Never | 56 (25) |
| Do you manage patients with MS? | |
| Yes | 144 (64.3) |
| No | 80 (35.7) |
| Types of management used for MS | |
| Education | 14 (6.3) |
| Diet advice | 14 (6.3) |
| Exercise advice | 8 (3.6) |
| Medications | 0 (0) |
| All of above | 196 (87.5) |
| None of above | 8 (3.6) |
| Have you attended a training course on MS. | |
| Yes | 34 (15.2) |
| No | 190 (84.8) |
| Barriers to applying the clinical criteria of MS | |
| Busy clinic | 160 (71.4) |
| Not enough knowledge | 85 (37.9) |
| Complicated cases | 66 (29.5) |
| Not from family medicine core | 5 (2.2) |
| Others | 16 (7.1) |
Figure 1Overall knowledge, attitudes, and practices of family medicine residents regarding MS
Comparison of participants based on level of MS knowledge
| Variables | Knowledge |
| |
|---|---|---|---|
|
| |||
| High (>75%) | Low (<75%) | ||
| Age (years) | 27.6±2.1 | 27.7±2.4 | 0.758@ |
| Age groups | |||
| <30 | 71 (89.9) | 124 (85.5) | 0.353* |
| ≥30 | 8 (10.1) | 21 (14.5) | |
| Sex | |||
| Male | 32 (40.5) | 74 (51) | 0.132* |
| Female | 47 (59.5) | 71 (49) | |
| Nationality | |||
| Saudi | 79 (100) | 143 (98.6) | 0.541* |
| Non-Saudi | 0 (0) | 2 (1.4) | |
| Training Centre | |||
| KFMC | 30 (38) | 65 (44.8) | 0.321* |
| KSMC | 23 (29.1) | 30 (20.7) | 0.156* |
| KSUMC | 8 (10.1) | 17 (11.7) | 0.717* |
| SFH | 6 (7.6) | 8 (5.5) | 0.571* |
| PSMNC | 6 (7.6) | 19 (13.1) | 0.211* |
| NGHA | 2 (2.5) | 1 (0.7) | 0.285* |
| PMAH | 4 (5.1) | 5 (3.4) | 0.724* |
| Training Level | |||
| R1 | 19 (24.1) | 48 (33.1) | 0.157* |
| R2 | 19 (24.1) | 36 (24.8) | 0.897* |
| R3 | 26 (32.9) | 36 (24.8) | 0.196* |
| R4 | 15 (19) | 25 (17.2) | 0.744* |
*Chi square test, @independent sample t-test
Comparison of participants based on attitudes toward MS
| Variables | Attitude |
| |
|---|---|---|---|
|
| |||
| Positive (>75%) | Low (<75%) | ||
| Age (years) | 27.7±2.3 | 27.5±2.2 | 0.418@ |
| Age group | |||
| <30 | 122 (85.3) | 73 (90.1) | 0.303* |
| ≥30 | 21 (14.7) | 8 (9.9) | |
| Sex | |||
| Male | 77 (53.8) | 29 (35.8) | 0.009* |
| Female | 66 (46.2) | 52 (64.2) | |
| Nationality | |||
| Saudi | 142 (99.3) | 80 (98.8) | 1.000* |
| Non-Saudi | 1 (0.7) | 1 (1.2) | |
| Training Centre | |||
| KFMC | 71 (49.7) | 24 (29.6) | 0.004* |
| KSMC | 28 (19.6) | 25 (30.9) | 0.056* |
| KSUMC | 12 (8.4) | 13 (16) | 0.080* |
| SFH | 11 (7.7) | 3 (3.7) | 0.236* |
| PSMNC | 13 (9.1) | 12 (14.8) | 0.191* |
| NGHA | 2 (1.4) | 1 (1.2) | 1.000* |
| PMAH | 6 (4.2) | 3 (3.7) | 1.000* |
| Training Level | |||
| R1 | 46 (32.2) | 21 (25.9) | 0.327* |
| R2 | 36 (25.2) | 19 (23.5) | 0.774* |
| R3 | 39 (27.3) | 23 (28.4) | 0.857* |
| R4 | 22 (15.4) | 18 (22.2) | 0.199* |
*Chi square test, @independent sample t-test
Comparison of participants regarding MS practices
| Variables | Practice |
| |
|---|---|---|---|
|
| |||
| High (>50%) | Low (<50%) | ||
| Age (years) | 27.7±1.8 | 27.6±2.6 | 0.747@ |
| Age group | |||
| <30 | 98 (87.5) | 97 (86.6) | 0.842* |
| ≥30 | 14 (12.5) | 15 (13.4) | |
| Sex | |||
| Male | 60 (53.6) | 46 (41.1) | 0.061* |
| Female | 52 (46.4) | 66 (58.9) | |
| Nationality | |||
| Saudi | 111 (99.1) | 111 (99.1) | 1.000* |
| Non-Saudi | 1 (0.9) | 1 (0.9) | |
| Training Centre | |||
| KFMC | 41 (36.6) | 54 (48.2) | 0.079* |
| KSMC | 29 (25.9) | 24 (21.4) | 0.432* |
| KSUMC | 14 (12.5) | 11 (9.8) | 0.524* |
| SFH | 5 (4.5) | 9 (8) | 0.270* |
| PSMNC | 17 (15.2) | 8 (7.1) | 0.056* |
| NGHA | 1 (0.9) | 2 (1.8) | 1.000* |
| PMAH | 5 (4.5) | 4 (3.6) | 1.000* |
| Training Level | |||
| R1 | 25 (22.3) | 42 (37.5) | 0.013* |
| R2 | 29 (25.9) | 26 (23.2) | 0.641* |
| R3 | 31 (27.7) | 31 (27.7) | 1.000* |
| R4 | 27 (24.1) | 13 (11.6) | 0.015* |
*Chi square test, @independent sample t-test